Influence of Age, Gender, Frailty, and Body Mass Index on Serum IL-17A Levels in Mature Type 2 Diabetic Patients

Zvonimir Bosnić; František Babič; Thomas Wittlinger; Viera Anderková; Ines Šahinović; Ljiljana Trtica Majnarić

doi:10.12659/MSM.940128

14 October 2023 : Clinical Research

Influence of Age, Gender, Frailty, and Body Mass Index on Serum IL-17A Levels in Mature Type 2 Diabetic Patients

Zvonimir Bosnić^1ABEF, František Babič

^2CDEG*, Thomas Wittlinger^34DEG, Viera Anderková^2C, Ines Šahinović

^5B, Ljiljana Trtica Majnarić^16ABDEF

DOI: 10.12659/MSM.940128

Med Sci Monit 2023; 29:e940128

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 6 (A) IL-17A in men and women <65 years old, distributed according to differences in the frailty status and BMI categories. (B) IL-17A in men and women ≥65 years old, distributed according to differences in the frailty status and BMI categories. R, 4.3.1, R Development Core Team.

Back to the Article

Influence of Age, Gender, Frailty, and Body Mass Index on Serum IL-17A Levels in Mature Type 2 Diabetic Patients

Your Privacy